A detailed history of Lathrop Investment Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Lathrop Investment Management Corp holds 3,890 shares of ABT stock, worth $458,086. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,890
Previous 3,690 5.42%
Holding current value
$458,086
Previous $383,000 15.67%
% of portfolio
0.08%
Previous 0.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $20,014 - $23,626
200 Added 5.42%
3,890 $443,000
Q2 2023

Aug 02, 2023

SELL
$100.78 - $112.29 $2,015 - $2,245
-20 Reduced 0.54%
3,690 $402,000
Q1 2023

Apr 20, 2023

SELL
$96.86 - $114.01 $40,196 - $47,314
-415 Reduced 10.06%
3,710 $376,000
Q4 2022

Jan 17, 2023

BUY
$95.06 - $111.52 $39,449 - $46,280
415 Added 11.19%
4,125 $453,000
Q3 2022

Oct 27, 2022

SELL
$96.76 - $112.03 $33,866 - $39,210
-350 Reduced 8.62%
3,710 $359,000
Q1 2022

Apr 19, 2022

SELL
$114.02 - $139.04 $13,112 - $15,989
-115 Reduced 2.75%
4,060 $481,000
Q3 2021

Oct 15, 2021

SELL
$116.66 - $129.06 $11,666 - $12,906
-100 Reduced 2.34%
4,175 $493,000
Q1 2021

Apr 19, 2021

SELL
$108.84 - $128.23 $49,086 - $57,831
-451 Reduced 9.54%
4,275 $512,000
Q4 2020

Jan 26, 2021

BUY
$105.0 - $114.42 $36,015 - $39,246
343 Added 7.83%
4,726 $517,000
Q2 2020

Jul 30, 2020

BUY
$76.57 - $98.0 $382 - $490
5 Added 0.11%
4,383 $401,000
Q1 2020

Apr 15, 2020

SELL
$62.82 - $91.86 $219,178 - $320,499
-3,489 Reduced 44.35%
4,378 $345,000
Q4 2019

Jan 24, 2020

BUY
$78.51 - $87.4 $25,515 - $28,405
325 Added 4.31%
7,867 $683,000
Q1 2019

Apr 19, 2019

SELL
$66.22 - $80.06 $1,986 - $2,401
-30 Reduced 0.4%
7,542 $603,000
Q4 2018

Feb 08, 2019

BUY
$65.56 - $74.27 $76,574 - $86,747
1,168 Added 18.24%
7,572 $548,000
Q3 2017

Oct 11, 2017

BUY
$48.06 - $53.64 $307,776 - $343,510
6,404
6,404 $342,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Lathrop Investment Management Corp Portfolio

Follow Lathrop Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lathrop Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lathrop Investment Management Corp with notifications on news.